3HNS image
Deposition Date 2009-06-01
Release Date 2009-07-21
Last Version Date 2024-11-27
Entry Detail
PDB ID:
3HNS
Keywords:
Title:
CS-35 Fab Complex with Oligoarabinofuranosyl Hexasaccharide
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CS-35 Fab Heavy Chain
Chain IDs:A (auth: H)
Chain Length:220
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:CS-35 Fab Light Chain
Chain IDs:B (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Structural insights into antibody recognition of mycobacterial polysaccharides.
J.Mol.Biol. 392 381 392 (2009)
PMID: 19577573 DOI: 10.1016/j.jmb.2009.06.074

Abstact

Mycobacteria are major human pathogens responsible for such serious and widespread diseases as tuberculosis and leprosy. Among the evolutionary adaptations essential for pathogenicity in mycobacteria is a complex carbohydrate-rich cell-wall structure that contains as a major immunomodulatory molecule the polysaccharide lipoarabinomannan (LAM). We report here crystal structures of three fragments from the non-reducing termini of LAM in complex with a murine antibody Fab fragment (CS-35Fab). These structures reveal for the first time the three-dimensional structures of key components of LAM and the molecular basis of LAM recognition at between 1.8- and 2.0-A resolution. The antigen-binding site of CS-35Fab forms three binding pockets that show a high degree of complementarity to the reducing end, the branch point and one of the non-reducing ends of the Y-shaped hexasaccharide moiety found at most of the non-reducing termini of LAM. Structures of CS-35Fab bound to two additional tetrasaccharides confirm the general mode of binding seen in the hexasaccharide and indicate how different parts of LAM are recognized. Altogether, these structures provide a rational basis for understanding the overall architecture of LAM and identify the key elements of an epitope that may be exploited for the development of novel and more effective anti-mycobacterial vaccines. Moreover, this study represents the first high-resolution X-ray crystallographic investigation of oligofuranoside-protein recognition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures